Evidence map›Paper›PMID 33731178›Full record

ArticleGlobalization and health2021

Countries with delayed COVID-19 introduction - characteristics, drivers, gaps, and opportunities.

Zheng Li, Cynthia Jones, Girum S Ejigu, Nisha George, Amanda L Geller, Gregory C Chang, Alys Adamski, Ledor S Igboh, Rebecca D Merrill, Philip Ricks and 2 more

Abstract read
In one paragraph

Article in Globalization and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zheng LiCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA. ZJLi@cdc.gov.ORCID 0000-0003-2140-9246
Cynthia JonesCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Girum S EjiguCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Nisha GeorgeCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Amanda L GellerCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Gregory C ChangCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Alys AdamskiCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Ledor S IgbohCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Rebecca D MerrillCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Philip RicksCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Sara A MirzaCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.
Michael LynchCenters for Disease Control and Prevention, COVID-19 Response, 4770 Buford Highway, Atlanta, GA, 30341, USA.

Funding

CIHRWellcome Trust
6 · The paper itself

Abstract

backgroundThree months after the first reported cases, COVID-19 had spread to nearly 90% of World Health Organization (WHO) member states and only 24 countries had not reported cases as of 30 March 2020. This analysis aimed to 1) assess characteristics, capability to detect and monitor COVID-19, and disease control measures in these 24 countries, 2) understand potential factors for the reported delayed COVID-19 introduction, and 3) identify gaps and opportunities for outbreak preparedness, particularly in low and middle-income countries (LMICs). We collected and analyzed publicly available information on country characteristics, COVID-19 testing, influenza surveillance, border measures, and preparedness activities in these countries. We also assessed the association between the temporal spread of COVID-19 in all countries with reported cases with globalization indicator and geographic location.

resultsTemporal spreading of COVID-19 was strongly associated with countries' globalization indicator and geographic location. Most of the 24 countries with delayed COVID-19 introduction were LMICs; 88% were small island or landlocked developing countries. As of 30 March 2020, only 38% of these countries reported in-country COVID-19 testing capability, and 71% reported conducting influenza surveillance during the past year. All had implemented two or more border measures, (e.g., travel restrictions and border closures) and multiple preparedness activities (e.g., national preparedness plans and school closing).

conclusionsLimited testing capacity suggests that most of the 24 delayed countries may have lacked the capability to detect and identify cases early through sentinel and case-based surveillance. Low global connectedness, geographic isolation, and border measures were common among these countries and may have contributed to the delayed introduction of COVID-19 into these countries. This paper contributes to identifying opportunities for pandemic preparedness, such as increasing disease detection, surveillance, and international collaborations. As the global situation continues to evolve, it is essential for countries to improve and prioritize their capacities to rapidly prevent, detect, and respond, not only for COVID-19, but also for future outbreaks.

Indexed as

Global HealthPublic Health SurveillanceCOVID-19COVID-19 TestingDisease OutbreaksHumansInfluenza, HumanPandemicsTravelWorld Health OrganizationBorder control measuresCOVID-19Global healthPandemicPreparednessSurveillance

Identifiers

PMID33731178
PMCPMC7968140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.